Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas

Abstract

We searched for chromosome 3p homo- and hemizygous losses in 23 lung cancer cell lines, 53 renal cell and 22 breast carcinoma biopsies using 31 microsatellite markers located in frequently deleted 3p regions. In addition, two sequence-tagged site markers (NLJ-003 and NL3-001) located in the Alu-PCR clone 20 region (AP20) and lung cancer (LUCA) regions, respectively, were used for quantitative real-time PCR (QPCR). We found frequent (10–18%) homozygous deletions (HDs) in both 3p21.3 regions in the biopsies and lung cancer cell lines. In addition, we discovered that amplification of 3p is a very common (15–42.5%) event in these cancers and probably in other epithelial malignancies. QPCR showed that aberrations of either NLJ-003 or NL3-001 were detected in more than 90% of all studied cases. HDs were frequently detected simultaneously both in NLJ-003 or NL3-001 loci in the same tumour (P<3–10−7). This observation suggests that tumour suppressor genes (TSG) in these regions could have a synergistic effect. The exceptionally high frequency of chromosome aberrations in NLJ-003 and NL3-001 loci suggests that multiple TSG(s) involved in different malignancies are located very near to these markers. Precise mapping of 15 independent HDs in the LUCA region allowed us to establish the smallest HD region in 3p21.3C located between D3S1568 (CACNA2D2 gene) and D3S4604 (SEMA3F gene). This region contains 17 genes. Mapping of 19 HDs in the AP20 region resulted in the localization of the minimal region to the interval flanked by D3S1298 and D3S3623 markers. Only four genes were discovered in this interval, namely, APRG1, ITGA9, HYA22 and VILL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

ACTB :

human β-actin gene

AI:

allelic imbalance

AP20:

Alu-PCR clone 20 region

BC:

breast carcinoma

C:

centromeric

CC:

cervical carcinoma

H-allele:

high-molecular-weight allele

HD:

homozygous deletion

L-allele:

low-molecular-weight allele

LOH:

loss of heterozygosity

LUCA:

lung cancer region

MEC:

major epithelial carcinomas

NSCLC:

non-small cell lung cancer

PF2K :

phosph-fructo-2 kinase gene

QPCR:

quantitative real-time PCR

RCC:

renal cell carcinoma

STS:

sequence-tagged site

SCLC:

small-cell lung cancer

T:

telomeric

TSG:

tumour suppressor gene

References

  • Alimov A, Kost-Alimova M, Liu J, Li C, Bergerheim U, Imreh S, Klein G and Zabarovsky ER . (2000). Oncogene, 19, 1392–1399.

  • Angeloni D, Duh F-M, Moody M, Dean M, Zabarovsky ER, Sentchenko V, Braga E and Lerman MI . (2003). Mol. Cell. Probes, 17, 55–57.

  • Angeloni D and Lerman MI . (2001). Sourcebook on Asbestos Diseases, Vol. 23. Peters GA and Peters BJ (eds). Philadelphia: Lexis Nexis Press, pp 169–209.

    Google Scholar 

  • Braga E, Pugacheva E, Bazov I, Ermilova V, Kazubskaya T, Mazurenko N, Kisseljov F, Liu J, Garkavtseva R, Zabarovsky E and Kisselev L . (1999). FEBS Lett., 454, 215–219.

  • Braga E, Senchenko V, Bazov I, Loginov W, Liu J, Ermilova V, Kazubskaya T, Garkavtseva R, Mazurenko N, Kisseljov F, Lerman MI, Klein G, Kisselev L and Zabarovsky ER . (2002). Int. J. Cancer, 100, 534–541.

  • Daigo Y, Isomura M, Nishiwaki T, Tamari M, Ishikawa S, Kai M, Murata Y, Takeuchi K, Yamane Y, Hayashi R, Minami M, Fujino MA, Hojo Y, Uchiyama I, Takagi T and Nakamura Y . (1999). DNA Res., 6, 37–44.

  • Danilkovitch-Miagkova A, Duh F-M, Kuzmin I, Angeloni D, Liu SL, Miller AD and Lerman MI . (2003). Proc. Natl. Acad. Sci. USA, 100, 4580–4585.

  • Erlandsson R . (1998). Cancer Genet. Cytogenet., 104, 1–18.

  • Girard L, Zochbauer-Muller S, Virmani A, Gazdar AF and Minna JD . (2000). Cancer Res., 60, 4894–4906.

  • Imreh S, Klein G and Zabarovsky E . (2003). Genes Chromosomes Cancer, 38, 307–321.

  • Ishikawa S, Kai M, Tamari M, Takei Y, Takeuchi K, Bandou H, Yamane Y, Ogawa M and Nakamura Y . (1997). DNA Res., 4, 35–43.

  • Kashuba VI, Gizatullin RZ, Protopopov AI, Li J, Vorobieva NV, Fedorova L, Zabarovska VI, Muravenko OV, Kost-Alimova M, Domninsky DA, Kiss C, Allikmets R, Zakharyev VM, Braga EA, Sumegi J, Lerman M, Wahlestedt C, Zelenin AV, Sheer D, Winberg G, Grafodatsky A, Kisselev LL, Klein G and Zabarovsky ER . (1999). Gene, 239, 259–271.

  • Kashuba VI, Szeles A, Allikmets RL, Nilsson AS, Bergerheim SR, Modi W, Grafodatsky A, Dean M, Stanbridge EJ, Winberg G, Klein G and Zabarovsky ER . (1995). Cancer Genet. Cytogenet., 81, 144–150.

  • Kashuba VI, Li J, Wang F, Senchenko VN, Protopopov A, Malyukova A, Kutsenko AS, Kadyrova E, Zabarovska VI, Muravenko OV, Zelenin AV, Kisselev LL, Kuzmin I, Minna JD, Winberg G, Ernberg I, Braga E, Lerman MI, Klein G and Zabarovsky ER . (2004). Proc. Natl. Acad. Sci. USA, 101, 4906–4911.

  • Kok K, Naylor SL and Buys CH . (1997). Adv. Cancer Res., 71, 27–92.

  • Lerman M, Minna J, Sekido Y, Bader S, Burbee D, Fong K, Forgacs E, Gao B, Garner H, Gazdar AF, Girard L, Kamibayashi C, Kondo M, Pande A, Ramalingam V, Randle D, Tomizawa Y, Virmani A, Wistuba I, Macartney D, Honorio S, Maher E, Latif F, Kashuba V, Protopopov A, Li J, Klein G, Zabarovsky E, Duh F-M, Wei M-H, Geil L, Kuzmin I, Ivanov S, Angeloni D, Ivanova A, Zbar B and Johnson BE . (2000). The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res., 60, 6116–6133.

    CAS  PubMed  Google Scholar 

  • Lindblad-Toh K, Tanenbaum DM, Daly MJ, Winchester E, Lui W-O, Villapakkam A, Stanton SE, Larsson C, Hudson TJ, Johnson BE, Lander ES and Meyerson M . (2000). Nat. Biotechnol., 18, 1001–1005.

  • Liu J, Zabarovska VI, Braga E, Alimov A, Klein G and Zabarovsky ER . (1999). FEBS Lett., 462, 121–128.

  • Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn Jr PA, Carney D, Minna JD and Mulshine JL . (1996). J. Cell. Biochem., 24 (Suppl), 32s–91s.

  • Protopopov A, Kashuba VI, Zabarovska VI, Muravenko OV, Lerman MI, Klein G and Zabarovsky ER . (2003). Cancer Res., 63, 404–412.

  • Sambrook J, Fritsch EF and Maniatis T . (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbour Laboratory Press: Cold Spring Harbor, NY.

    Google Scholar 

  • Seabright M . (1971). Lancet, 7731, 971–972.

  • Senchenko V, Liu J, Braga E, Mazurenko N, Loginov W, Seryogin Y, Bazov I, Protopopov A, Kiseljov F, Kashuba V, Lerman MI, Klein G and Zabarovsky ER . (2003). Oncogene, 22, 2984–2992.

  • Stewart BW and Kleihues P . (2003). World Cancer Report. IARC Press: Lyon.

    Google Scholar 

  • Van den Berg A and Buys CH . (1997). Genes Chromosomes Cancer, 19, 59–76.

  • Wei M-F, Latif F, Bader S, Kashuba V, Chen JY, Duh F-M, Sekido Y, Lee C, Geil L, Kuzmin I, Zabarovsky E, Klein G, Zbar B, Minna JD and Lerman MI . (1996). Cancer Res., 56, 1487–1492.

  • Wistuba II, Behrens C, Virmani AK, Meme G, Milchgrub S, Girard L, Fondon III JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF and Minna JD . (2000). Cancer Res., 60, 1949–1960.

  • Wistuba II, Gazdar AF and Minna JD . (2001). Semin. Oncol., 28, 3–13.

  • Yang Q, Yoshimura G, Mori I, Sakurai T and Kakudo K . (2002). J. Hum. Genet., 47, 453–459.

  • Zabarovsky ER, Lerman MI and Minna JD . (2002). Oncogene, 21, 6915–6935.

  • Zöchbauer-Muller S, Gazdar AF and Minna JD . (2002). Annu. Rev. Physiol., 64, 681–708.

Download references

Acknowledgements

This work was supported by research grants from the Swedish Cancer Society, the Swedish Research Council, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), Karolinska Institute, Åke Wibergs Stiftelse, the Royal Swedish Academy of Sciences, the Swedish Institute, INTAS, the Russian Foundation for Basic Research (Grant 01-04-48028), the research programme of Russian Academy of Science ‘Basic Science to Medicine’ and Russian Ministry of Science and Technology. MIL and DA were funded in toto with funds from the National Cancer Institute, National Institutes of Health, under Contract No. NO1-CO-56000. JDM was supported by Grants P50CA70907 and CA71618. The content of the publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eugene R Zabarovsky.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Senchenko, V., Liu, J., Loginov, W. et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 23, 5719–5728 (2004). https://doi.org/10.1038/sj.onc.1207760

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207760

Keywords

This article is cited by

Search

Quick links